Urska Janzic

10PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 25, 2026
Transition from Parenteral to Subcutaneous Application of Systemic Oncological Therapy for Treating Non-Small-Cell Lung Cancer.

|Jul 12, 2025
The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study.

Filip Marković, Maximilian Hochmair, Nino Müser

|May 07, 2025
Benefit of Consolidation Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer Patients Treated with Immunotherapy: Data from Slovenian Cohort.

Marina Čakš, Urška Janžič, Tjaša Rutar

|Apr 13, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos

|Mar 28, 2024
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes.

Urska Janzic, Andrej Janzic, Abed Agbarya

|Oct 24, 2023
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments.

Abed Agbarya, Ina Sarel, Tomer Ziv-Baran

Pageof 2

Frequent Collaborators

3 joint publications

Abed Agbarya

2 joint publications

Urska Bidovec-Stojkovic

2 joint publications

Matija Rijavec

2 joint publications

Marko Jakopovic